Original paper
Neoadjuvant Therapy for Resectable Pancreatic Cancer
Abstract
The aim of this study was to pool data from randomized controlled trials (RCT) limited to resectable pancreatic ductal adenocarcinoma (PDAC) to determine whether a neoadjuvant therapy impacts on disease-free survival (DFS) and surgical outcome.Few underpowered studies have suggested benefits from neoadjuvant chemo (± radiation) for strictly resectable PDAC without offering conclusive recommendations.Three RCTs were identified comparing...
Paper Details
Title
Neoadjuvant Therapy for Resectable Pancreatic Cancer
Published Date
Jul 29, 2021
Journal
Volume
274
Issue
5
Pages
713 - 720
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History